Florian M. Wagenlehner
Elite in Asymptomatic Bacteriuria

Florian M. Wagenlehner

Rudolf Buchheim Str. 7, 
Giessen, HE, DE 
Elite in Asymptomatic Bacteriuria
Rudolf Buchheim Str. 7, 
Giessen, HE, DE 
OverviewLocationsClinical Research

Overview

Florian Wagenlehner practices in Giessen, Germany. Mr. Wagenlehner is rated as an Elite expert by MediFind in the treatment of Asymptomatic Bacteriuria. His top areas of expertise are Urinary Tract Infection (UTI), Interstitial Nephritis, Epididymitis, Lithotripsy, and Hormone Replacement Therapy (HRT).

His clinical research consists of co-authoring 389 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 17 articles in the study of Asymptomatic Bacteriuria.

Gender
Male

Locations

Rudolf Buchheim Str. 7, Giessen, HE 35392, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
A Phase III, Randomized, Multicenter, Parallel-Group, Double-Blind, Double-Dummy Study in Adolescent and Adult Female Participants Comparing the Efficacy and Safety of Gepotidacin to Nitrofurantoin in the Treatment of Uncomplicated Urinary Tract Infection (Acute Cystitis)
Enrollment Status: Completed
Publish Date: June 22, 2023
Intervention Type: Drug
Study Drugs: Gepotidacin, Nitrofurantoin
Study Phase: Phase 3

389 Total Publications

A retrospective global study of the prevalence of O-serotypes of invasive Escherichia coli disease in patients admitted to tertiary care hospitals.
A retrospective global study of the prevalence of O-serotypes of invasive Escherichia coli disease in patients admitted to tertiary care hospitals.
Journal: Epidemiology and infection
Published: September 03, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wagenlehner's expertise for a condition
ConditionClose
View All 39 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile